WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer

Purpose: Advanced prostate cancer (PCa) has limited treatment regimens and shows low response to chemotherapy and immunotherapy, leading to poor prognosis. Histone modification is a vital mechanism of gene expression and a promising therapy target. In this study, we characterized WD repeat domain 5...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Theranostics
Päätekijät: Zhou, Qianghua, Chen, Xu, He, Haixia, Peng, Shengmeng, Zhang, Yangjie, Zhang, Jingtong, Cheng, Liang, Liu, Sen, Huang, Ming, Xie, Ruihui, Lin, Tianxin, Huang, Jian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2021
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7978315/
https://ncbi.nlm.nih.gov/pubmed/33754029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.55814
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia